Ken Griffin Nkarta, Inc. Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Nkarta, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 17,600 shares of NKTX stock, worth $39,952. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,600
Previous 53,500
67.1%
Holding current value
$39,952
Previous $241,000
82.16%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NKTX
# of Institutions
119Shares Held
61.3MCall Options Held
17.6KPut Options Held
1.11M-
Ra Capital Management, L.P. Boston, MA10.8MShares$24.5 Million0.44% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$9.21 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$8.55 Million2.88% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$8.1 Million0.63% of portfolio
-
Sr One Capital Management, LP3.33MShares$7.57 Million3.09% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $110M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...